Considering that in the present work, AKT1 was identified as the target of COP, it is reasonable to suppose that COP represses the activation of PI3K/AKT signaling and the related malignant behaviors of bladder cancer cells via directly suppressing AKT1. This evidence concerns the gene AKT1 and urinary bladder cancer.